Vanzacaftor/Tezacaftor/Deutivacaftor

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vanzacaftor/Tezacaftor/Deutivacaftor, covering 2026-02-05 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Long-Term Safety and Efficacy of Vanzacaftor/Tezacaftor/Deutivacaftor in Cystic Fibrosis Participants 1 Year of Age and Older [Phase 3]

See pricing